400 related articles for article (PubMed ID: 17616659)
1. Patterns of known and novel small RNAs in human cervical cancer.
Lui WO; Pourmand N; Patterson BK; Fire A
Cancer Res; 2007 Jul; 67(13):6031-43. PubMed ID: 17616659
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA expression profiling and Notch1 and Notch2 expression in minimal deviation adenocarcinoma of uterine cervix.
Lee H; Kim KR; Cho NH; Hong SR; Jeong H; Kwon SY; Park KH; An HJ; Kim TH; Kim I; Yoon HK; Suh KS; Min KO; Choi HJ; Park JY; Yoo CW; Lee YS; Lee HJ; Lee WS; Park CS; Lee Y;
World J Surg Oncol; 2014 Nov; 12():334. PubMed ID: 25381598
[TBL] [Abstract][Full Text] [Related]
3. Altered MicroRNA expression in cervical carcinomas.
Lee JW; Choi CH; Choi JJ; Park YA; Kim SJ; Hwang SY; Kim WY; Kim TJ; Lee JH; Kim BG; Bae DS
Clin Cancer Res; 2008 May; 14(9):2535-42. PubMed ID: 18451214
[TBL] [Abstract][Full Text] [Related]
4. Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth.
Wang X; Tang S; Le SY; Lu R; Rader JS; Meyers C; Zheng ZM
PLoS One; 2008 Jul; 3(7):e2557. PubMed ID: 18596939
[TBL] [Abstract][Full Text] [Related]
5. Dysregulated microRNA expression in adenocarcinoma of the uterine cervix: clinical impact of miR-363-3p.
Park H; Lee MJ; Jeong JY; Choi MC; Jung SG; Joo WD; Lee C; An HJ
Gynecol Oncol; 2014 Dec; 135(3):565-72. PubMed ID: 25230213
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-497 is a potential prognostic marker in human cervical cancer and functions as a tumor suppressor by targeting the insulin-like growth factor 1 receptor.
Luo M; Shen D; Zhou X; Chen X; Wang W
Surgery; 2013 Jun; 153(6):836-47. PubMed ID: 23453369
[TBL] [Abstract][Full Text] [Related]
7. [Differential expression of miR-21, miR-126, miR-143, miR-373 in normal cervical tissue, cervical cancer tissue and Hela cell].
Liu L; Wang YL; Wang JF
Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Jul; 43(4):536-9. PubMed ID: 22997891
[TBL] [Abstract][Full Text] [Related]
8. Profiling of microRNA-mRNA reveals roles of microRNAs in cervical cancer.
Ma D; Zhang YY; Guo YL; Li ZJ; Geng L
Chin Med J (Engl); 2012 Dec; 125(23):4270-6. PubMed ID: 23217399
[TBL] [Abstract][Full Text] [Related]
9. [The role of microRNAs in the pathogenesis of cervical cancer and its relationship to HPV].
Zhu YK; Cheng N; Hu Y; Cen YZ
Sheng Li Ke Xue Jin Zhan; 2012 Aug; 43(4):251-6. PubMed ID: 23189617
[TBL] [Abstract][Full Text] [Related]
10. Aberrant microRNA expression in human cervical carcinomas.
Rao Q; Shen Q; Zhou H; Peng Y; Li J; Lin Z
Med Oncol; 2012 Jun; 29(2):1242-8. PubMed ID: 21264530
[TBL] [Abstract][Full Text] [Related]
11. Aberrant expression of miR-20a and miR-203 in cervical cancer.
Zhao S; Yao DS; Chen JY; Ding N
Asian Pac J Cancer Prev; 2013; 14(4):2289-93. PubMed ID: 23725129
[TBL] [Abstract][Full Text] [Related]
12. Let-7 miRNA Precursors Co-express with LIN28B in Cervical Cells.
Zamora-Contreras AM; Alvarez-Salas LM
Microrna; 2018; 7(1):62-71. PubMed ID: 29336272
[TBL] [Abstract][Full Text] [Related]
13. The expression of miR-21 and miR-143 is deregulated by the HPV16 E7 oncoprotein and 17β-estradiol.
Gómez-Gómez Y; Organista-Nava J; Ocadiz-Delgado R; García-Villa E; Leyva-Vazquez MA; Illades-Aguiar B; Lambert PF; García-Carrancá A; Gariglio P
Int J Oncol; 2016 Aug; 49(2):549-58. PubMed ID: 27278606
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients.
Torres A; Torres K; Pesci A; Ceccaroni M; Paszkowski T; Cassandrini P; Zamboni G; Maciejewski R
Int J Cancer; 2013 Apr; 132(7):1633-45. PubMed ID: 22987275
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA expression in cervical cancer: Novel diagnostic and prognostic biomarkers.
Gao C; Zhou C; Zhuang J; Liu L; Liu C; Li H; Liu G; Wei J; Sun C
J Cell Biochem; 2018 Aug; 119(8):7080-7090. PubMed ID: 29737570
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and prognostic microRNAs in stage II colon cancer.
Schepeler T; Reinert JT; Ostenfeld MS; Christensen LL; Silahtaroglu AN; Dyrskjøt L; Wiuf C; Sørensen FJ; Kruhøffer M; Laurberg S; Kauppinen S; Ørntoft TF; Andersen CL
Cancer Res; 2008 Aug; 68(15):6416-24. PubMed ID: 18676867
[TBL] [Abstract][Full Text] [Related]
17. Distinct cervical microRNA profiles are present in women destined to have a preterm birth.
Elovitz MA; Brown AG; Anton L; Gilstrop M; Heiser L; Bastek J
Am J Obstet Gynecol; 2014 Mar; 210(3):221.e1-11. PubMed ID: 24565431
[TBL] [Abstract][Full Text] [Related]
18. A systematic study on dysregulated microRNAs in cervical cancer development.
He Y; Lin J; Ding Y; Liu G; Luo Y; Huang M; Xu C; Kim TK; Etheridge A; Lin M; Kong D; Wang K
Int J Cancer; 2016 Mar; 138(6):1312-27. PubMed ID: 26032913
[TBL] [Abstract][Full Text] [Related]
19. Systematic gene microarray analysis of the lncRNA expression profiles in human uterine cervix carcinoma.
Chen J; Fu Z; Ji C; Gu P; Xu P; Yu N; Kan Y; Wu X; Shen R; Shen Y
Biomed Pharmacother; 2015 May; 72():83-90. PubMed ID: 26054679
[TBL] [Abstract][Full Text] [Related]
20. A microRNA expression signature for cervical cancer prognosis.
Hu X; Schwarz JK; Lewis JS; Huettner PC; Rader JS; Deasy JO; Grigsby PW; Wang X
Cancer Res; 2010 Feb; 70(4):1441-8. PubMed ID: 20124485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
